Salk Team Raises Funds for Pancreatic Cancer Research
Pedal the Cause makes largest contribution to funding cancer research
Nearly $3 million was raised by last year’s Padres Pedal the Cause cycling event, providing crucial funding for novel cancer research in San Diego, including Salk faculty.
Salk Institute scientists Professor Tony Hunter, Assistant Professor Graham McVicker, Professor Joseph Ecker and Helmsley-Salk Fellow Jesse Dixon were among the collaborative teams of researchers and medical professionals to receive funding to study pediatric and brain cancers.
The 2019 Salk Cancer Center team included 54 riders, walkers, runners and volunteers who joined together with more than 3,000 others in an effort to support cutting-edge research to accelerate cures for cancer. The event took place on November 16, and highlights included riding over the Coronado Bridge, through Coronado and on the Silver Strand. All cycling routes, which ranged from 25 miles to 100 miles, ended on center field at Petco Park in downtown San Diego.
Padres Pedal the Cause provides research grants to cross-institutional teams of scientists and physicians from four of San Diego’s top cancer organizations: Salk Institute, Moores Cancer Center at UC San Diego Health, Rady Children’s Hospital and Sanford Burnham Prebys Medical Discovery Institute. The annual cycling event has raised over $10 million since its inception in 2013, funding 59 projects on all types of cancers.
Awarded semi-annually by peer review, Salk’s Innovation Grants Program is critical to sustaining emerging science
Innovation GrantsProfessor Juan Carlos Izpisua Belmonte seeks to determine whether epigenetic inheritance can take place in mammals across generations. If possible, this would mean that the experiences that have shaped the genetic expression of parents (e.g., adaptations to environmental challenges) could be passed to children—a significant question in evolutionary biology, which remains unanswered. Associate Professor Sreekanth Chalasani, Postdoctoral Fellow Chen-min Yeh and Staff Scientist Gerald Pao seek to answer the question of whether or not brain activity can be used to control a robot. They will leverage advanced live microscopy techniques, in addition to supercomputer technology, to see whether or not the brain activity of zebrafish larvae can control a fish robot. Professor and Laboratory Head David Schubert and Staff Scientist Antonio Currais are identifying new drug candidates for Alzheimer’s disease using screens for mitochondrial dysfunction. Specifically, they will look at a large library of plant extracts that have pharmacological value to see whether any have protective traits that are able to preserve mitochondrial function—one of the earliest clinical challenges in Alzheimer’s. Director and Professor Joseph Ecker is working to develop a method that allows researchers to record the transcriptional activity within a cell into the genetic code so that they can analyze the cascade of transcriptional events that occurs during an organism’s development as well as cell reprogramming. Professor Edward Callaway is undertaking a project that will develop innovative methods for flexible, high-throughput analysis of specific brain-cell types across any species, including humans, that can identify the genetic enhancers that restrict expression of genes that have been passed from one cell (or whole organism) to another.
Innovation Collaborative GrantsDirectors and Professors Ronald Evans and Susan Kaech and Associate Professor Ye Zheng will lead a team in exploring if a healthy diet and exercise reduces levels of inflammation and renders tumor cells more sensitive to the immune system, with the goal of expanding the efficacy of immunotherapies. Professors Alan Saghatelian, Joseph Noel and Jan Karlseder will undertake a multi-pronged approach to develop small-molecule inhibitors of the DNA repair regulator CYREN, with the goal of specifically sensitizing tumor cells to genotoxic therapy.
The 2019-2020 Rose Hills Foundation Innovator Grant ProgramAssistant Professor Kenta Asahina was named The Rose Hills Foundation’s 2019-2020 Innovator Grant Program awardee, in coordination with Salk’s Innovation Grants Program. The award provides $100,000 for Asahina to explore a novel approach to studying aging. Asahina, who is holder of the Helen McLoraine Developmental Chair in Neurobiology, will study how the nervous system can contribute to life span difference between sexes. Females in many animal species, including humans, live longer than males. Asahina’s work aims to provide a novel paradigm for studying aging, with a potential to understand the biological mechanisms that specify human lifespan.
New rankings place Salk scientists among most highly cited in world
Salk Scientists Margarita Behrens and Joseph Ecker awarded $1.6 million to expand human cell atlas
The Kavli Foundation gifts Salk $3 million for cutting-edge neuroscience research
In August, The Kavli Foundation committed $3 million to support ongoing neuroscience research at the Salk Institute as part of the joint UCSD-Salk Kavli Institute for Brain and Mind (KIBM). The gift—matched by an additional $3 million from Salk—brings $6 million to the KIBM endowment to enable faculty in neuroscience to work on questions whose answers will have the most impact in the field.
The Kavli Institute for Brain and Mind was established through a $15.5 million endowment commitment from The Kavli Foundation, shared between Salk and UC San Diego. KIBM’s mission aims to support research that furthers an understanding of the origins, evolution and mechanisms of human cognition, from the brain’s physical and biochemical machinery to the experiences and behaviors called the mind.
The Salk Institute is home to many of the world’s leaders within the field of neuroscience, which includes computational neuroscience, spinal circuitry, pain, movement, learning, vision, psychiatric and developmental disorders, and age-related decline.
The Kavli Foundation also generously gifted $300,000 to Salk Professor and new KIBM member Kay Tye, holder of the Wylie Vale Chair.
Tye’s lab seeks to understand the neural-circuit basis of emotion that leads to motivated behaviors such as social interaction, reward-seeking and avoidance. Her lab employs a multidisciplinary approach to find mechanistic explanations for how these emotional and motivational states influence behavior in health and disease.
“The Kavli Institute for Brain and Mind is a nexus for neuroscience research, helping to facilitate collaborations across two world-renowned institutes—Salk and UC San Diego—as well as other neuroscience research centers around the world,” says Stephanie Albin, science program officer at The Kavli Foundation.
In recognition of the $3 million matching gift, Salk has named Institute laboratory space the Kavli Institute for Brain and Mind Laboratories for Neurobiology. The lab space is for research conducted by the following up-and-coming neuroscientists: Nicola Allen, associate professor and the Hearst Foundation Developmental Chair; Kenta Asahina, assistant professor and holder of the Helen McLoraine Developmental Chair in Neurobiology; Eiman Azim, assistant professor and the William Scandling Developmental Chair; and Xin Jin, associate professor.
- The Promise and Perils of Big DataSalk scientists are unlocking the power of "big data" to make unprecedented discoveries in neuroscience, cancer and other areas.
- Joseph Noel – Learning from LagoonsInside Salk sat down with Noel to learn about his path to becoming a scientist and about his current work researching coastal wetlands to help combat climate change.
- Krishna Vadodaria – Uncovering the mysteries of depressionStaff Scientist Krishna Vadodaria's research on human neurons is helping to uncover the biological basis for psychiatric disorders and why some depressed patients do not respond to SSRIs.